Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11 | N/A | N/A | N/A | 305 |
| Receivables | 2,762 | N/A | N/A | N/A | N/A |
| Inventories | 9,635 | N/A | N/A | N/A | N/A |
| TOTAL | $12,800 | $N/A | $N/A | $N/A | $703 |
| Non-Current Assets | |||||
| PPE Net | 1,594 | N/A | N/A | N/A | N/A |
| Intangibles | 23,334 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 9,493 | 0 | 0 | 0 | 0 |
| TOTAL | $34,421 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $47,221 | $N/A | $N/A | $N/A | $703 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,114 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,304 | 0 | 0 | 0 | 797 |
| TOTAL | $12,550 | $N/A | $N/A | $N/A | $819 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,323 | N/A | N/A | N/A | 2,644 |
| Other Non-Current Liabilities | 31,406 | 0 | 0 | 0 | 0 |
| TOTAL | $37,729 | $N/A | $N/A | $N/A | $2,644 |
| Total Liabilities | $50,268 | $N/A | $N/A | $N/A | $3,463 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 54 |
| Common Shares | N/A | N/A | N/A | N/A | 27 |
| Retained earnings | -196,102 | N/A | N/A | N/A | -193,277 |
| TOTAL | $-3,058 | $N/A | $N/A | $N/A | $-2,760 |
| Total Liabilities And Equity | $47,210 | $0 | $0 | $0 | $703 |